Abstract
Locally recurrent and advanced breast cancer (including inflammatory breast cancer-like type) is one of the most difficult conditions to cure, and new therapies are needed. If sufficient boron compound can be targeted to the tumor, boron neutron capture therapy (BNCT) can be applied to locally recurrent and advanced breast cancer. In this study, we performed preliminary dosimetry with a phantom model of the mammary gland at the Kyoto University Research Reactor (KUR) and feasibility dosimetry with JCDS at the JRR4 reactor at the Japan Atomic Research Institute.
We performed preliminary dosimetry of a phantom model of the mammary gland with thermal neutron irradiation (OO-0011 mode) on LiF collimation at KUR. The thermal neutron flux was 5.16 E + 08 cm-2 s−1 at the surface of the phantom. The blood boron concentration is estimated to be 30 ppm, and the tumor boron concentration to be 90 ppm, according to which the tumor/blood ratio is 3 and the skin/blood ratio is 1.2. The tumor RBE dose is estimated to be 47 Gy/h, and the skin RBE dose is 12.4 Gy/h.
For recurrent breast cancer, we performed a feasibility estimation of a 3D construction of the tumor according to the MRI imaging of a patient with epithermal neutron mode at JRR4. The blood-boron concentration (ppm) and tumor/normal tissue ratio are estimated to be 24 and 3.5, respectively. The skin RBE dose is restricted to 10 Gy/h. The maximum tumor RBE dose, minimum tumor RBE dose, and mean tumor RBE dose are 64.3, 16.6, and 46.5 Gy, respectively, in half hour irradiation.
In this study, we showed the possibility to apply BNCT to locally recurrent and advanced breast cancer. We can irradiate tumors as selectively and safety as possible, reducing the effects on neighboring healthy tissues.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J (2006) Loco-regional recurrence after mastectomy in high-risk breast cancer–risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials. Radiother Oncol 79(2):147–155
Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TA (2008) Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 72(2):474–484
Cameron DA, Stein S (2008) Drug insight: intracellular inhibitors of HER2 – clinical development of lapatinib in breast cancer. Nat Clin Pract Oncol 5(9):512–520
Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, Jagiello-Gruszfeld A, Crown J, Chan A, Kaufman B, Skarlos D, Campone M, Davidson N, Berger M, Oliva C, Rubin SD, Stein S, Cameron D (2006) Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med 355(26):2733–2743
Ballo MT, Strom EA, Prost H, Singletary SE, Theriault RL, Buchholz TA, McNeese MD (1999) Local-regional control of recurrent breast carcinoma after mastectomy: does hyperfractionated accelerated radiotherapy improve local control? Int J Radiat Oncol Biol Phys 44(1):105–112
Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, McNeese MD (2000) Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys 47(5):1191–1200
Touboul E, Buffat L, Belkacémi Y, Lefranc JP, Uzan S, Lhuillier P, Faivre C, Huart J, Lotz JP, Antoine M, Pène F, Blondon J, Izrael V, Laugier A, Schlienger M, Housset M (1999) Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 43(1):25–38
Willner J, Kiricuta IC, Kölbl O (1997) Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 37(4):853–863
Chung CS, Harris JR (2007) Post-mastectomy radiation therapy: translating local benefits into improved survival. Breast 16(Suppl 2):S78–S83
Hiraoka M, Mitsumori M, Shibuya K (2002) Adjuvant radiation therapy following mastectomy for breast cancer. Breast Cancer 9(3):190–195
Wagner FM, Kneschaurek P, Kastenmüller A, Loeper-Kabasakal B, Kampfer S, Breitkreutz H, Waschkowski W, Molls M, Petry W (2008) The munich fission neutron therapy facility MEDAPP at the research reactor FRM II. Strahlenther Onkol 184(12):643–646
Walshe JM, Swain SM (2005–2006) Clinical aspects of inflammatory breast cancer. Breast Dis 22:35–44
Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R, Ueno NT, Buchholz TA, Singletary SE, Hortobagyi GN (2007) Inflammatory breast cancer (IBC) and patterns of recurrence, understanding the biology of a unique disease. Cancer 110(7):1436–1444
Kato I, Ono K, Sakurai Y, Ohmae M, Maruhashi A, Imahori Y, Kirihata M, Nakazawa M, Yura Y (2004) Effectiveness of BNCT for recurrent head and neck malignancies. Appl Radiat Isot 61(5):1069–1073
Aihara T, Hiratsuka J, Morita N, Uno M, Sakurai Y, Maruhashi A, Ono K, Harada T (2006) First clinical case of boron neutron capture therapy for head and neck malignancies using 18 F-BPA PET. Head Neck 28(9):850–855
Sakurai Y, Kobayashi T (2000) Characteristics of the KUR heavy water neutron irradiation facility as a neutron irradiation field with variable energy spectra. Nucl Instrum Meth A 453:569–596
Sakurai Y, Kobayashi T, Ono K et al (2002) Study on accelerator-base neutron irradiation field aiming for wider application in BNCT – spectrum shift and regional filtering. In: Sauerwein W (ed) Research and development in neutron capture therapy. Monduzzi Editore, Bologna, pp 259–263
Yanagie H, Sakurai Y, Ogura K, Kobayashi T, Furuya Y, Sugiyama H, Kobayashi H, Ono K, Nakagawa K, Takahashi H, Eriguchi M (2007) Evaluation of neutron dosimetry on pancreatic cancer phantom model for application of intraoperative boron neutron-capture therapy. Biomed Pharmacother 61(9):505–514
Kumada H (2001) The development of a computational dosimetry system for BNCT at JRR-4. In: Hawthorne MF (ed) Frontiers in neutron capture therapy. Kluwer, New York, pp 611–614
Yanagie H, Kumada H, Sakurai Y, Nakamura T, Furuya Y, Sugiyama H, Ono K, Takamoto, S, Eriguchi M, Takahashi H (2009) Dosimetric evaluation of neutron capture therapy for local recurrenced breast cancer. Appl Radiact Isot 67(7-8 Supp):S63–66
Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, Takagaki M, Ono K, Ido T, Fujii R (1998) Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin Cancer Res 4:1825–1832
Rich JN (2007) Cancer stem cells in radiation resistance. Cancer Res 67(19):8980–8984
Yanagie H, Ogata A, Sugiyama H, Eriguchi M, Takamoto S, Takahashi H (2008) Application of drug delivery system to boron neutron capture therapy for cancer. Expert Opin Drug Deliv 5(4):427–443
Yanagie H, Tomita T, Kobayashi H, Fujii Y, Takahashi T, Hasumi K, Nariuchi H, Sekiguchi M (1991) Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br J Cancer 63(4):522–526
Yanagie H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi K, Eriguchi M, Kobayashi T, Ono K (1997) Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br J Cancer 75(5):660–665
Wei Q, Kullberg EB, Gedda L (2003) Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studies. Int J Oncol 23(4):1159–1165
Yanagie H, Kobayashi H, Takeda Y, Yoshizaki I, Nonaka Y, Naka S, Nojiri A, Shinnkawa H, Furuya Y, Niwa H, Ariki K, Yasuhara H, Eriguchi M (2002) Inhibition of growth of human breast cancer cells in culture by neutron capture using 10B-containing liposomes. Biomed Pharmacother 56:93–99
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Yanagie, H. (2012). Application of Neutron Capture Therapy for Locally Recurrent Breast Cancer. In: Sauerwein, W., Wittig, A., Moss, R., Nakagawa, Y. (eds) Neutron Capture Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-31334-9_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-31334-9_27
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-31333-2
Online ISBN: 978-3-642-31334-9
eBook Packages: MedicineMedicine (R0)